PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Short Interest Up ∞ in April

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totaling 3,774 shares, a growth of ∞ from the April 15th total of 0 shares. Based on an average daily trading volume, of 984,095 shares, the short-interest ratio is presently 0.0 days.

PharmaTher Stock Down 1.8%

Shares of OTCMKTS PHRRF opened at $0.05 on Friday. PharmaTher has a 1-year low of $0.04 and a 1-year high of $0.55. The business has a 50-day moving average of $0.05 and a 200-day moving average of $0.07.

About PharmaTher

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.